Teclistamab Plus Autologous Lymphocyte Infusion (ALI) for the Treatment of R/R Multiple Myeloma

NCT06880601 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myleoma
Multiple Myeloma in Relapse
Multiple Myeloma Refractory

Interventions

DRUG: Teclistamab

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto